The study, “Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment,” also in AJMC®'s May issue, was included in the National Pharmaceutical Council’s Monday CER Daily Newsfeed. The study found that formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.
MultiBriefs included an AJMC® published study in its article on outpatient pharmacies. The study, “Impact of a Pharmacy-Based Transitional Care Program on Hospital Readmissions,” found that patients receiving postdischarge care from pharmacists had a 28% lower risk of readmission at 30 days and a 31.9% lower risk at 180 days compared with usual care.